
Granisetron HCL Tablets
| Product/Composition | Granisetron HCL Tablets |
|---|---|
| Strength | 1mg |
| Form | Tablets |
| Production Capacity | 10 Million Tablets/Month |
| Packaging | 5 X 10 Tablets / Box |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
Granisetron HCl Tablets are a medicine used to prevent nausea and vomiting, particularly those caused by chemotherapy, radiation therapy, or surgery. They belong to a class of drugs called 5-HT3 receptor antagonists.
Here are the key details:
-
Composition: Each tablet contains Granisetron hydrochloride, commonly in strengths such as 1 mg or 2 mg.
-
Dosage Form: Oral tablets, usually taken once or twice daily, as prescribed by a doctor.
-
Mode of Action:
-
Granisetron blocks serotonin (5-HT3) receptors in the brain and gastrointestinal tract.
-
This prevents the activation of the vomiting reflex, reducing nausea and vomiting.
-
-
Uses:
-
Chemotherapy-induced nausea and vomiting (CINV).
-
Radiation-induced nausea and vomiting (RINV).
-
Postoperative nausea and vomiting (PONV) after surgery.
-
-
Treatment Goal: To prevent or control nausea and vomiting, improving patient comfort and adherence to treatment.
-
Side Effects:
-
Common: headache, constipation, dizziness, fatigue.
-
Less common/serious: allergic reactions, irregular heartbeat, severe dizziness, low blood pressure.
-
-
Precautions:
-
Use caution in patients with heart rhythm disorders.
-
Inform the doctor about other medications, especially those affecting heart rhythm.
-
Not recommended during pregnancy or breastfeeding unless prescribed.
-
Adequate hydration and monitoring may be advised during chemotherapy or post-surgery.
-
👉 Granisetron HCl is effective for preventing nausea and vomiting by blocking serotonin signals that trigger the vomiting reflex, making it widely used in oncology and surgical settings.